Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
Crossref DOI link: https://doi.org/10.1186/s12931-017-0681-z
Published Online: 2017-12-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donohue, James F.
Goodin, Thomas
Tosiello, Robert
Wheeler, Alistair
Funding for this research was provided by:
Sunovion Pharmaceuticals, Inc.